πŸ‡ΊπŸ‡Έ FDA
Patent

US 8236846

Dual-acting antihypertensive agents

granted A61KA61K31/415A61K31/4164

Quick answer

US patent 8236846 (Dual-acting antihypertensive agents) held by Theravance, Inc. expires Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Aug 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/415, A61K31/4164, A61K31/417, A61K31/4188